Peyona 20 mg

Peyona 20 mg is a caffeine citrate solution used for intravenous administration. It is commonly used to stimulate breathing in premature infants. This medication is manufactured by Chiesi Farmaceutici S.p.A. in Italy.

Peyona 20 mg is primarily used to stimulate respiratory drive in premature infants who experience breathing difficulties. Caffeine citrate, the active ingredient, helps to reduce the frequency of apnea and improve breathing patterns. This medication is often administered in neonatal intensive care units to support respiratory function in newborns.

Common effects of Peyona 20 mg may include increased alertness and improved breathing in premature infants. The medication works by stimulating the respiratory center in the brain, which can help regulate breathing. Some infants may experience temporary side effects, but these are generally mild and manageable.

Peyona 20 mg should be administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration guidelines to ensure safety. Patients with certain medical conditions or allergies should inform their healthcare provider before using this medication.

Peyona 20 mg may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with caffeine citrate, so it is advisable to consult with a healthcare professional.